Enterprises can move past GenAI hype by using product-aligned operating models, AI-ready data and strong governance to scale ...

Hedera network reports strong Q3 results with rising HBAR value, expanding user adoption, and key mainnet upgrades that boost ...

While PayMe loves experimenting with new technology, they also ensure that every product is fully aligned with the RBI’s ...

The public will get a chance to provide input to regulators on a Lancaster city data center's proposed second phase, a two-story building expected to total 735,128 square feet and cost as much as $2.5 ...

Artificial intelligence (AI) has entered a stage where computational demand is outpacing traditional infrastructure capacity. As AI models grow in scale and complexity, centralized systems struggle to ...

Kyverna Therapeutics (KYTX) announced positive interim data from the Phase 2 portion of the registrational KYSA-6 clinical trial of KYV-101 in generalized myasthenia gravis, or gMG. The data will be ...

Artificial Intelligence has become the engine of modern business — from automated logistics and smart retail to predictive finance and personalized ...

H.C. Wainwright reiterates a Buy rating and $9 price target on Armata Pharmaceuticals (ARMP) after the company shared new data from the recently completed Phase 2a diSArm study in a late-breaking oral ...

IMNN-001 program is currently advancing its OVATION 3 pivotal Phase 3 trial per plan LAWRENCEVILLE, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN) , a clinical-stage company in ...

GLASGOW, Scotland, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Causeway Therapeutics, a clinical-stage biotechnology company developing novel medicines for tendon disease, today announced positive topline data ...

RenderMan 27 brings XPU final-frame rendering, deep compositing, Solaris integration, and VFX Reference Platform 2024 ...